Alfigen , Inc.

Industry:

Medical Testing & Clinical Laboratories

Description

Quality: Alfigen's laboratory provides thorough and accurate diagnosis with efficient turnaround time and all testing is conducted with state-of-the-art equipment, strict adherence to rigorous guidelines, and a relentless focus on quality. Every test result is reviewed by multiple specialists, including a board-certified geneticist, and the final report is customized to the client's needs. Alfigen is accredited by CAP, certified by CLIA, and licensed in California, Florida, Maryland, and New York.

Service: Alfigen offers unparalleled customer service, providing every effort to ensure consistent high culture success rates and fewer repeat tests. Every client receives personal attention throughout the entire testing process. The company has developed its own proprietary laboratory information system that allows reports to be customized to the client's needs. Customized billing, consultations, interpretative support, specimen collection and shipping supplies, and genetic counseling are also available.

Expertise: For more than twenty years, Alfigen has focused on clinical genetics laboratory services. The staff, of more than one hundred employees, includes physicians and a Ph.D. with board certifications in clinical genetics, pediatrics, clinical cytogenetics, clinical molecular genetics, clinical pathology, and hematopathology. There are also a large number of highly trained technical personnel and genetic counselors.

Education: Alfigen is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Conferences on a wide array of topics are scheduled periodically. An Update Series offered with Category 1 CME credits is published quarterly and mailed to referring physicians. The company can also provide CME programs tailored to our client's needs.

News Archive

Other News To Note. BIOWORLD Today; 11/4/2009 ...discovery and development efforts. o Alfigen Inc., of Pasadena, Calif., appointed...succeeds Ahmed Alfi, who will remain Alfigen's chairman and will focus on business...and strategic planning. Privately held Alfigen is a genetic and esoteric testing company... ...more

Genzyme Has Satisfying Quarter; Cerezyme Gives 'Upside Surprise'. BIOWORLD Today; 11/3/2009 ...600 million last year. Amortization of $26.2 million included the acquisitions of SangStat and Pasadena, Calif.-based Alfigen Inc. Cerezyme (imiglucerase for injection), for Type I Gaucher's disease, sold $203 million for the first quarter... ...more